CEL-SCI Reports Fiscal 2016 Financial Results And Clinical & Corporate Developments
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM) ("CEL SCI" or the "Company") reported financial results today for the fiscal year ended September 30, 2016. The Company also reported key clinical and corporate developments achieved during and subsequent to fiscal 2016.
Clinical and Corporate Developments included:
• CEL-SCI raised net proceeds of approximately $21.42 million during fiscal 2016.
Clinical and Corporate Developments included:
• CEL-SCI raised net proceeds of approximately $21.42 million during fiscal 2016.